MATCH MY THESIS IVS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  20.4% 15.9% 13.7% 13.6% 18.7%  
Credit score (0-100)  7 13 17 17 7  
Credit rating  B BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5

Net sales  407 370 818 801 199  
Gross profit  348 332 591 636 131  
EBITDA  -1.0 8.4 9.9 -23.0 0.5  
EBIT  -1.0 8.4 9.9 -23.0 0.5  
Pre-tax profit (PTP)  -1.9 7.9 7.8 -25.1 -0.2  
Net earnings  -1.9 6.2 6.0 -24.3 -0.2  
Pre-tax profit without non-rec. items  -1.9 7.9 7.8 -25.1 -0.2  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  24.7 30.9 36.9 12.7 12.5  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  60.1 61.4 219 125 30.8  

Net Debt  -60.1 -23.8 -211 -109 -15.0  
 
See the entire balance sheet

Volume 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5

Net sales  407 370 818 801 199  
Net sales growth  0.0% -9.0% 120.9% -2.1% -75.2%  
Gross profit  348 332 591 636 131  
Gross profit growth  0.0% -4.7% 78.0% 7.6% -79.4%  
Employees  0 0 0 0 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  60 61 219 125 31  
Balance sheet change%  0.0% 2.2% 256.6% -43.1% -75.3%  
Added value  -1.0 8.4 9.9 -23.0 0.5  
Added value %  -0.2% 2.3% 1.2% -2.9% 0.2%  
Investments  0 0 0 0 0  

Net sales trend  0.0 -1.0 1.0 -1.0 -2.0  
EBIT trend  -1.0 1.0 2.0 -1.0 1.0  

Profitability 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5
EBITDA %  -0.2% 2.3% 1.2% -2.9% 0.2%  
EBIT %  -0.2% 2.3% 1.2% -2.9% 0.2%  
EBIT to gross profit (%)  -0.3% 2.5% 1.7% -3.6% 0.4%  
Net Earnings %  -0.5% 1.7% 0.7% -3.0% -0.1%  
Profit before depreciation and extraordinary items %  -0.5% 1.7% 0.7% -3.0% -0.1%  
Pre tax profit less extraordinaries %  -0.5% 2.1% 0.9% -3.1% -0.1%  
ROA %  -1.6% 13.8% 7.0% -13.4% 0.6%  
ROI %  -3.9% 30.2% 29.1% -92.6% 3.7%  
ROE %  -7.8% 22.2% 17.8% -97.8% -1.7%  

Solidity 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5
Equity ratio %  41.2% 50.4% 16.9% 10.2% 40.5%  
Relative indebtedness %  8.7% 8.2% 22.2% 14.0% 9.2%  
Relative net indebtedness %  -6.1% 1.8% -3.6% 0.4% 1.7%  
Net int. bear. debt to EBITDA, %  6,269.1% -283.5% -2,141.6% 473.7% -3,209.7%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5
Quick Ratio  1.7 2.0 1.2 1.1 1.7  
Current Ratio  1.7 2.0 1.2 1.1 1.7  
Cash and cash equivalent  60.1 23.8 211.0 108.9 15.0  

Capital use efficiency 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5
Trade debtors turnover (days)  0.0 37.0 0.0 0.0 0.0  
Trade creditors turnover (days)  35.6 18.4 45.7 3.5 2.6  
Current assets / Net sales %  14.8% 16.6% 26.8% 15.6% 15.5%  
Net working capital  24.7 30.9 36.9 12.7 12.5  
Net working capital %  6.1% 8.3% 4.5% 1.6% 6.3%  

Employee efficiency 
2016
2017/5
2017
2018/5
2018
2019/5
2019
2020/5
2020
2021/5
Net sales / employee  0 0 0 0 99  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 -0